Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare…
| Métrica | REC.MI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 72.9% | 57.4% | +15.5% |
| Operating Margin | 31.0% | -34.4% | +65.4% |
| Net Margin | 24.4% | -32.5% | +56.9% |
| FCF Margin | 29.7% | -12.6% | +42.3% |
| ROE | 27.9% | -39.2% | +67.1% |
| ROA | 13.7% | -30.9% | +44.7% |
| Current Ratio | 1.36 | 2.73 | -1.37 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY21 | FY20 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 13.7% | — |
| ✓Flujo de caja operativo positivo | €492M | €404M |
| ✓Rentabilidad sobre activos al alza | 13.7% | 13.1% |
| ✓Caja operativa/activos supera al ROA | 17.5% | ROA 13.7% |
| –Menos deuda a largo plazo | — | — |
| ✓Mejor liquidez (ratio corriente) | 1.36 | 1.34 |
| ✗Sin aumentar el nº de acciones | — | — |
| ✓Margen bruto al alza | 72.9% | 71.9% |
| ✓Rotación de activos al alza | 0.56 | 0.53 |
| Calidad del negocio | FY21 |
|---|---|
| ✓Margen FCF > 10 % | 29.7% |
| ✓ROCE > 10 % | 22.4% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 11.9% |
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. IN BREVE RECORDATI S.P.A. cotiza a 52.95 EUR y tiene una capitalización bursátil de €11.0B. Datos fundamentales de los informes financieros anuales oficiales (ESEF) vía filings.xbrl.org; cuentas anuales, sin trimestrales.Más empresas del sector Salud